Belgian biopharma UCB and Cradle, the Amsterdam-based AI protein design and engineering company, have announced a strategic ...
German family-owned pharma major Boehringer Ingelheim and Sino Biopharmaceutical, together with its subsidiaries (SBP Group), ...
In the wake of the Democrats sweep of Congress, Leerink Partners analyst David Risinger highlighted potential implications ...
Ask a biopharma commercial team where to launch first and, until recently, the answer was mostly about opportunity. Most ...
Oncology company BeOne Medicines said the US Food and Drug Administration has accepted and granted Priority Review to its ...
With the COINS Act around the corner, Chinese biotech companies are feeling the pressure of heightened regulatory scrutiny ...
Japanese drugmaker Nxera Pharma today announced that its has entered into an exclusive global license agreement with US ...
US biotech major Amgen reported third-quarter 2026 revenues of $10.37 billion, up 8% year-on-year and ahead of analyst ...
US pharma major AbbVie has expanded its UK research and development facility in Oxford as part of more than £120 million ...
Swiss biotech Idorsia announced that the US Food and Drug Administration (FDA) has granted Breakthrough Therapy designation ...
Few medicines have left as clear a mark on drug regulation as thalidomide. Its use as a sedative in the late 1950s and early ...
French pharma company Servier said its recently acquired muscular dystrophy candidate sevasemten failed to meet the primary ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results